Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes - Wikidata - awgldk - TriplyDB

Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes

Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes

http://www.wikidata.org/entity/Q35804201

about

Hypertension and hyperglycemia synergize to cause incipient renal tubular alterations resulting in increased NGAL urinary excretion in rats Early detection of diabetic kidney disease: Present limitations and future perspectives Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease Clinical Predictive Factors in Diabetic Kidney Disease Progression Role of Inflammation in Muscle Homeostasis and Myogenesis Biomarkers in kidney fibrosis: are they useful?Biomarkers of Renal Disease and Progression in Patients with Diabetes The Prevalence and Management of Diabetic Nephropathy in Asia Molecular mechanisms of diabetic kidney disease Soluble Fn14 Is Detected and Elevated in Mouse and Human Kidney Disease Effects of Tumor Necrosis Factor-α on Podocyte Expression of Monocyte Chemoattractant Protein-1 and in Diabetic Nephropathy Clinical therapeutic strategies for early stage of diabetic kidney disease.Synergism between circulating tumor necrosis factor receptor 2 and HbA(1c) in determining renal decline during 5-18 years of follow-up in patients with type 1 diabetes and proteinuria.A story of microalbuminuria and diabetic nephropathy Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis Inflammatory Cytokines as Uremic Toxins: "Ni Son Todos Los Que Estan, Ni Estan Todos Los Que Son".Advice to follow a low-carbohydrate diet has a favourable impact on low-grade inflammation in type 2 diabetes compared with advice to follow a low-fat diet.Soluble TNF receptors and kidney dysfunction in the elderly.Circulating TNF receptors predict cardiovascular disease in patients with chronic kidney disease.Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy.Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study Role of podocyte B7-1 in diabetic nephropathy Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitus Circulating TNF receptors are significant prognostic biomarkers for idiopathic membranous nephropathy Intersection of cardiovascular disease and kidney disease: atrial fibrillation.Metabolism, energetics, and lipid biology in the podocyte - cellular cholesterol-mediated glomerular injury.Diabetic nephropathy - complications and treatment.Transcriptome analysis of proximal tubular cells (HK-2) exposed to urines of type 1 diabetes patients at risk of early progressive renal function decline.Risk of ESRD and all cause mortality in type 2 diabetes according to circulating levels of FGF-23 and TNFR1.Diabetic nephropathy in a sibling and albuminuria predict early GFR decline: a prospective cohort study Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease.Urinary biomarkers for early diabetic nephropathy: beyond albuminuria.Exosomal proteins as potential diagnostic markers in advanced non-small cell lung carcinoma.Soluble tumor necrosis factor receptor 1 and 2 predict outcomes in advanced chronic kidney disease: a prospective cohort study.Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes.Lipid biology of the podocyte--new perspectives offer new opportunities.Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy.Hepcidin-25 in diabetic chronic kidney disease is predictive for mortality and progression to end stage renal disease.Effects of sevelamer carbonate on advanced glycation end products and antioxidant/pro-oxidant status in patients with diabetic kidney disease.A panel of novel biomarkers representing different disease pathways improves prediction of renal function decline in type 2 diabetes.

P2860

Q21558791-1DCE9EAB-F9AF-41FA-A40D-1BB6950482C9 Q26741494-16C84FA0-7AC0-44E1-8194-0C58B4974CF0 Q26747131-93B1072B-E8F6-47DA-9A99-77B64ACBFA9B Q26749494-22AB2DAE-D044-4ED1-B2FE-CC9F240465BC Q26778322-2F62F0F6-D0C1-4D08-9601-DCD71D6DA1F9 Q26796625-6BEF7F4A-0007-4CB7-BA8F-4540F52F49C2 Q26799505-EFBD9204-651F-4485-A82D-908E9E56AE63 Q26851262-FE8B5136-5A45-48FD-BD8B-36003211042C Q27003963-9C3E2237-BD70-401A-9F64-B6F2F9E2E336 Q27347256-7139E040-81E1-42A5-87E6-3BA1F9056754 Q28080888-32A44DE7-ABFE-4BA0-8D33-336E235C2D25 Q30363683-5AC1B723-1C04-47A8-AF74-70C2E986FE46 Q30371076-B9A39819-B7F0-45BA-9D06-44C4FB6048DA Q30486667-D0A8A89F-41B7-4E27-AFFF-032D016379D8 Q33583018-D433AA90-21FF-4662-AB3E-923AA162A8ED Q33611989-B26D7034-DC66-4C98-B8AD-24809E43B9A0 Q33630095-BE8BA20C-0DEC-4255-9466-80A1E6E83305 Q33660677-0A31375C-C6E9-4981-BB71-025A83C6A5A4 Q33672484-C1CF3335-3B3F-479B-98BA-E182E394611F Q33772238-97A51AC0-DC2D-40C4-989C-7A4696D6BFC6 Q33810793-814D53AF-7591-472C-9216-D90828753666 Q33814864-A1B2D349-2549-4914-A583-C39E6765CFA3 Q33897901-0D109E95-8969-4CB9-BFFE-D131DDB9602A Q34011274-D6BD8AEA-C450-456D-A371-F5AEBB317D57 Q34040279-EC09EA7B-48BC-4A3D-BF98-E9E82A6DB28B Q34336370-66B825B0-C239-46CC-B683-BE909D00996D Q34387952-FEE79398-A20F-4E92-92A8-880919E4DA53 Q34625564-7AC03286-A944-4CC3-B21F-B0D70B849315 Q34634066-F2ED5381-3055-49D4-B307-431B1578F491 Q34774837-A046F971-B5BD-4176-B592-BF3E20965AC3 Q34787780-887FE9AB-447D-429E-A73E-110BE2130BC6 Q35009712-2EE01C8F-A2FC-4DC8-96DD-5084B9014AC9 Q35143602-5A7F87E1-92C5-4C45-A815-5BB8E698049B Q35231318-5C5DC661-6392-4A4D-9B18-FC62AF848809 Q35243559-84F35902-806C-4811-A08A-6BCE666BB76B Q35285568-4C23C203-159F-4A92-B64B-565BE19DE220 Q35364638-839071EC-61DB-4E54-9170-4196182EDEB5 Q35499717-A548A48F-19E7-4DB1-8349-7FACAD8A1923 Q35576119-44AAD21A-F7D3-45A0-9BAA-5FAD7F2870B1 Q35606905-1D179DB0-BEFE-4806-BE10-77CDE79E336E

P2860

Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes

http://www.wikidata.org/entity/Q35804201

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes

@ast

Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes

@en

type

label

Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes

@ast

Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes

@en

prefLabel

Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes

@ast

Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes

@en

P1433

Q35804201-2FD08B89-AB32-49C2-A0C0-445A9092C191

P1476

Q35804201-BD0474F3-8A11-4DD8-AD10-721131C7EA8A

P2093

Q35804201-017CF161-FF9E-4560-9956-A1FC476F7BCC

Q35804201-22419CAA-271B-4C12-A9EF-BBEBBE3ACFB7

Q35804201-2F368E79-5A0A-4DD1-899F-DDDED82E7579

Q35804201-5FB1328F-B817-4286-B743-957F2BC0534B

Q35804201-772DFCBE-AA36-4E63-90B5-534F89D0990A

Q35804201-A056B764-6E6A-4642-A029-47E62BE11694

Q35804201-A99D9501-8666-4762-B86D-412284D4A5B0

Q35804201-AA52445D-8D21-49EF-97B1-FC6AB289D430

Q35804201-AEB58AF2-02F5-4734-BB56-D7EB7825A6FE

Q35804201-B1AF1D5F-537E-436D-8A83-795C671DED9F

P2860

Q35804201-01DA3FC1-E22B-4CFC-A536-51CE401EFAB8

Q35804201-10EAAEB2-6E1E-4CF9-9C8E-2D7C5206815F

Q35804201-1488C8B1-8AB4-44A1-B062-6708455C4E51

Q35804201-1A0F99E6-3BF4-4CDD-BBC1-BB7742199E3D

Q35804201-2A741E26-EE7F-401E-A9E9-910567AEA0BF

Q35804201-354660A7-ECED-4F05-A421-8D863FC2B513

Q35804201-3FD691B3-F330-4EBC-BF45-97B501CACD2A

Q35804201-422FEFF2-078E-492A-982D-A518FF673933

Q35804201-4C0B2B28-6A25-4828-B5B6-A6201E5D8E15

Q35804201-578D2A3F-7356-472B-8360-20151FB6E406

P304

Q35804201-96F135BD-5388-4F43-AA4A-70DEBB783DBB

P31

Q35804201-6CC27896-019D-4626-86BC-C16C92B88813

P356

Q35804201-2B50E368-AE4C-4F55-B9CC-A9CB01D68B2D

P433

Q35804201-316F2942-7FC4-4443-B731-594FCA786548

P478

Q35804201-0AC480E3-B005-457B-93D4-36C72819D71A

P50

Q35804201-5A92D8C6-12F7-4883-BAF7-E66D6ADA4A55

P577

Q35804201-30532A86-7445-4092-93BA-C612E577FF63

P5875

Q35804201-CC8F117F-517F-4093-BFB4-D496ED83CD66

P698

Q35804201-2CEE4B49-D2EE-4F20-97D4-1565FF6D4382

P921

Q35804201-578A245F-B24D-41B9-8F3E-8D24FA3C1761

Q35804201-5FF5F60D-1701-46B6-B91A-233B57CCEBA0

P932

Q35804201-0CD29F13-7BEB-47CC-A8BB-37D20A67CBB6

P356

P1433

Journal of the American Society of Nephrology

P1476

Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes

@en

P2093

Adam M Smiles

http://www.w3.org/2001/XMLSchema#string

Andrzej S Krolewski

http://www.w3.org/2001/XMLSchema#string

Florencia Rosetti

http://www.w3.org/2001/XMLSchema#string

James H Warram

http://www.w3.org/2001/XMLSchema#string

Jan Skupien

http://www.w3.org/2001/XMLSchema#string

John H Eckfeldt

http://www.w3.org/2001/XMLSchema#string

Monika A Niewczas

http://www.w3.org/2001/XMLSchema#string

Tanya N Mayadas

http://www.w3.org/2001/XMLSchema#string

Tomohito Gohda

http://www.w3.org/2001/XMLSchema#string

William H Walker

http://www.w3.org/2001/XMLSchema#string

P2860

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

Type 2 diabetes as an inflammatory disease

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

Association of kidney function with inflammatory and procoagulant markers in a diverse cohort: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis (MESA).

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

Lipid and inflammatory biomarkers and kidney function decline in type 2 diabetes.

Evaluating the yield of medical tests.

Inflammatory markers and the risk of coronary heart disease in men and women.

A primer and comparative review of major US mortality databases.

The association of serum lipids and inflammatory biomarkers with renal function in men with type II diabetes mellitus.

P304

507-515

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2011060627

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Alessandro Doria

P577

2012-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221936965

http://www.w3.org/2001/XMLSchema#string

P698

22266663

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

3294310

http://www.w3.org/2001/XMLSchema#string